Literature DB >> 8006433

Chronic cutaneous ulcers: etiology and epidemiology.

T J Phillips1.   

Abstract

The most commonly encountered chronic cutaneous ulcers in the United States are pressure ulcers and leg ulcers; this review is limited to the epidemiology of these ulcers. Chronic leg ulcers are frequently encountered in clinical practice but the extent of the problem is largely unknown. In particular, epidemiologic information within the United States is sadly lacking. Although there are more data available regarding the incidence and prevalence of pressure ulcers in acute and chronic care facilities, national surveys should be considered to obtain more accurate information on their incidence and prevalence. Multicenter studies are necessary to determine the epidemiology and cost of treating pressure ulcers by stage, setting, and other factors. Particular attention should be paid to high-risk groups such as spinal cord injury patients, the elderly, and those who are immobilized or chronically debilitated. Leg ulcers and pressure ulcers probably account for the majority of chronic cutaneous ulcers seen in the United States.

Entities:  

Mesh:

Year:  1994        PMID: 8006433     DOI: 10.1111/1523-1747.ep12388556

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  21 in total

Review 1.  Use of sugar on the healing of diabetic ulcers: a review.

Authors:  Atanu Biswas; Manish Bharara; Craig Hurst; Rainer Gruessner; David Armstrong; Horacio Rilo
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 2.  Comprehensive review of the clinical application of autologous mesenchymal stem cells in the treatment of chronic wounds and diabetic bone healing.

Authors:  Gerit D Mulder; Daniel K Lee; Nathan S Jeppesen
Journal:  Int Wound J       Date:  2012-02-28       Impact factor: 3.315

Review 3.  Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing.

Authors:  Omaida C Velazquez
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

4.  The use of marrow-derived stem cells to accelerate healing in chronic wounds.

Authors:  Lee C Rogers; Nicholas J Bevilacqua; David G Armstrong
Journal:  Int Wound J       Date:  2008-01-03       Impact factor: 3.315

Review 5.  Functions of skin-resident γδ T cells.

Authors:  Amanda S Macleod; Wendy L Havran
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

6.  Treatment of intractable skin ulcers caused by vascular insufficiency with allogeneic cultured dermal substitute: a report of eight cases.

Authors:  Tomonori Taniguchi; Yasuyuki Amoh; Kenichi Tanabe; Kensei Katsuoka; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2011-08-23       Impact factor: 1.731

7.  The linear excisional wound: an improved model for human ex vivo wound epithelialization studies.

Authors:  Amilcar Ezequiel Rizzo; Laurel A Beckett; Brian S Baier; R Rivkah Isseroff
Journal:  Skin Res Technol       Date:  2011-05-24       Impact factor: 2.365

8.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.

Authors:  Katherine A Gallagher; Zhao-Jun Liu; Min Xiao; Haiying Chen; Lee J Goldstein; Donald G Buerk; April Nedeau; Stephen R Thom; Omaida C Velazquez
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 9.  Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing.

Authors:  Zhao-Jun Liu; Omaida C Velazquez
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

10.  A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells.

Authors:  April E Nedeau; Richard J Bauer; Katherine Gallagher; Haiying Chen; Zhao-Jun Liu; Omaida C Velazquez
Journal:  Exp Cell Res       Date:  2008-04-25       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.